Premium
Belite Bio Inc (BLTE)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States. Its lead product candidate is Tinlarebant (LBS-008), an orally administered, which is in phase 3 clinical trial a... Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States. Its lead product candidate is Tinlarebant (LBS-008), an orally administered, which is in phase 3 clinical trial as an early intervention for maintaining the health and integrity of retinal tissues in stargardt disease type 1 and geographic atrophy patients. The company also develops LBS-009, an retinol binding protein 4 oral therapy, which is in preclinical development targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, as well as gout. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.73 | 1.22157887304 | 141.62 | 148.27 | 130 | 321571 | 141.76270143 | DR |
| 4 | -10.74 | -6.96995262509 | 154.09 | 158.645 | 130 | 239107 | 143.78991161 | DR |
| 12 | -18.66 | -11.5178075427 | 162.01 | 183.67 | 130 | 172873 | 153.75901605 | DR |
| 26 | -5.66 | -3.79840279176 | 149.01 | 200 | 130 | 194670 | 161.23717309 | DR |
| 52 | 83.24 | 138.479454334 | 60.11 | 200 | 56.1 | 142207 | 142.40702753 | DR |
| 156 | 128.01 | 834.485006519 | 15.34 | 200 | 11 | 90778 | 96.03161402 | DR |
| 260 | 130.85 | 1046.8 | 12.5 | 200 | 8.8 | 91107 | 74.9075649 | DR |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
